Patton Albertson Miller Group’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,282
Closed -$303K 242
2019
Q1
$303K Sell
1,282
-1,041
-45% -$328K 0.15% 101
2018
Q4
$736K Sell
2,323
-1,958
-46% -$625K 0.39% 66
2018
Q3
$1.29M Sell
4,281
-172
-4% -$59.2K 0.66% 52
2018
Q2
$1.29M Buy
4,453
+172
+4% +$48.4K 0.65% 56
2018
Q1
$1.17M Buy
4,281
+314
+8% +$97.5K 0.53% 60
2017
Q4
$1.26M Buy
3,967
+85
+2% +$27.3K 0.52% 63
2017
Q3
$1.26M Sell
3,882
-110
-3% -$32.6K 0.55% 66
2017
Q2
$1.16M Sell
3,992
-238
-6% -$62.9K 0.52% 66
2017
Q1
$1.1M Buy
4,230
+1,823
+76% +$515K 0.46% 75
2016
Q4
$683K Sell
2,407
-3
-0.1% -$889 0.29% 89
2016
Q3
$754K Sell
2,410
-249
-9% -$73.7K 0.33% 82
2016
Q2
$643K Buy
2,659
+136
+5% +$35.8K 0.29% 88
2016
Q1
$657K Buy
2,523
+133
+6% +$35.1K 0.33% 85
2015
Q4
$732K Sell
2,390
-827
-26% -$238K 0.37% 80
2015
Q3
$924K Buy
3,217
+55
+2% +$18.2K 0.49% 72
2015
Q2
$1.28M Buy
3,162
+1,650
+109% +$662K 0.56% 70
2015
Q1
$638K Buy
+1,512
New +$596K 0.26% 99

Other funds holding BIIB

Patton Albertson Miller Group's BIIB Position: Q2 2019 in Review

Patton Albertson Miller Group sold out of Biogen (BIIB) in Q2 2019, closing a stake of 1,282 shares — an estimated $303K sold.

Patton Albertson Miller Group first reported a position in BIIB in Q1 2015 and held it in 17 quarters. The position peaked at $1.29M in Q3 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • Patton Albertson Miller Group reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • Patton Albertson Miller Group sold 1,282 Biogen shares in Q2 2019, an estimated $303K.
  • Patton Albertson Miller Group first reported a position in Biogen in Q1 2015 and held it in 17 quarters.
  • Patton Albertson Miller Group's Biogen position peaked at $1.29M in Q3 2018.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Patton Albertson Miller Group's 13F filing for Q2 2019, filed 12 Aug 2019.